ARKX: Golden Dome and SpaceX IPO Reshape Space ETF Case

The ARK Space & Defense Innovation ETF (ARKX) has pulled back roughly 8% from its March high. The decline follows a strong run for the fund earlier this year. According to a Seeking Alpha analysis, the investment case is being reshaped by the U.S. Golden Dome missile defense program and the prospect of a SpaceX IPO.

Golden Dome, a multi-billion dollar defense initiative, could funnel contracts to several ARKX holdings, the analyst said. The program's scope is still being defined. Early Pentagon signals suggest a multi-year procurement cycle. Companies like L3Harris and Kratos are likely to compete for prime contracts, according to the analysis. The analyst described the exposure as indirect. It is material.

The SpaceX IPO is the more speculative catalyst. SpaceX has not confirmed a timeline. Market chatter intensified after its latest funding round. A public listing would force a revaluation of the entire space sector, the analyst wrote. SpaceX's revenue and valuation dwarf most publicly traded space companies. ARKX holds no direct SpaceX exposure. The ETF's holdings in launch providers and satellite manufacturers would benefit from a sector-wide rerating, the analyst said.

NASA's Commercial Lunar Payload Services contracts provide a different catalyst. These contracts are already flowing to companies like Intuitive Machines and Astrobotic. The contracts provide recurring revenue and a path to operational scale, according to the analyst. ARKX has a small allocation to CLPS-linked names. The program's expansion under the Artemis framework could broaden the beneficiary list.

Rocket Lab (RKLB), a key holding for the analyst, carries an Alpha Score of 38 on its AlphaScala page. The score reflects mixed signals on the company's risk-reward profile. The analyst holds a long position in RKLB. The analyst noted that RKLB's valuation already prices in some Golden Dome and CLPS upside. That leaves limited room for error. RKLB has won recent launch contracts. It faces execution risk on its Neutron rocket development.

The near-term pullback may reflect profit-taking, the analyst said. The ETF declined roughly 8% from its March high. The underlying thesis remains intact. The fund holds a concentrated portfolio in a handful of names. The analyst wrote that this means single-stock risk is higher than the ETF label suggests. The next concrete catalyst is a potential SpaceX IPO filing. That could come as early as the second half of 2025, the analyst wrote. Until then, the fund's performance will hinge on quarterly earnings from its defense and space holdings, the analyst said.